Response to: Cardiac drugs and outcome in COVID-19

被引：0
|
作者：
Goldstein, M. R. [1 ]
Poland, G. A. [2 ]
Graeber, C. W. [3 ,4 ,5 ,6 ]
机构：
[1] Ctr Hlth Living, NCH Phys Grp, 132 Moorings Pk Dr, Naples, FL 34105 USA
[2] Mayo Clin & Mayo Fdn, Mayo Vaccine Res Grp, 611C Guggenheim Bldg, Rochester, MN 55905 USA
[3] Mayo Clin, Coll Med & Sci, Naples, FL 34102 USA
[4] Univ Cent Florida, Coll Med, Naples, FL 34102 USA
[5] NCH Healthcare Syst Internal Med Residency, Naples, FL 34102 USA
[6] Mayo Clin, Sch Med & Sci, Naples, FL 34102 USA
来源：
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE | 2020年 / 113卷 / 07期
关键词：
D O I：
10.1093/qjmed/hcaa128
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：525 / 526
页数：2
相关论文
共 50 条
  • [31] COVID-19 and cardiac arrhythmias
    Bhatla, Anjali
    Mayer, Michael M.
    Adusumalli, Srinath
    Hyman, Matthew C.
    Oh, Eric
    Tierney, Ann
    Moss, Juwann
    Chahal, Anwar A.
    Anesi, George
    Denduluri, Srinivas
    Domenico, Christopher M.
    Arkles, Jeffrey
    Abella, Benjamin S.
    Bullinga, John R.
    Callans, David J.
    Dixit, Sanjay
    Epstein, Andrew E.
    Frankel, David S.
    Garcia, Fermin C.
    Kumareswaram, Ramanan
    Nazarian, Saman
    Riley, Michael P.
    Santangeli, Pasquale
    Schaller, Robert D.
    Supple, Gregory E.
    Lin, David
    Marchlinski, Francis
    Deo, Rajat
    HEART RHYTHM, 2020, 17 (09) : 1439 - 1444
  • [32] The therapeutic dilemma of immunosuppressive drugs for refractory cardiac sarcoidosis in COVID-19 infection
    Goto, Kohsaku
    Uehara, Masae
    Okamoto, Koh
    Takeda, Norifumi
    Morita, Hiroyuki
    Hatano, Masaru
    Komuro, Issei
    ESC HEART FAILURE, 2022, 8 (06): : 5577 - 5582
  • [33] The therapeutic dilemma of immunosuppressive drugs for refractory cardiac sarcoidosis in COVID-19 infection
    Goto, Kohsaku
    Uehara, Masae
    Okamoto, Koh
    Takeda, Norifumi
    Morita, Hiroyuki
    Hatano, Masaru
    Komuro, Issei
    ESC HEART FAILURE, 2021, 8 (06): : 5577 - 5582
  • [34] Dysregulation of the immune response affects the outcome of critical COVID-19 patients
    Wei, Lin-lin
    Wang, Wen-jing
    Chen, De-xi
    Xu, Bin
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (11) : 2768 - 2776
  • [35] The prevalence, risk factors and outcome of cardiac dysfunction in hospitalized patients with COVID-19
    Li, Yuman
    Li, He
    Li, Meng
    Zhang, Li
    Xie, Mingxing
    INTENSIVE CARE MEDICINE, 2020, 46 (11) : 2096 - 2098
  • [36] The relationship between cardiac injury, inflammation and coagulation in predicting COVID-19 outcome
    Alessandro Mengozzi
    Georgios Georgiopoulos
    Marco Falcone
    Giusy Tiseo
    Nicola Riccardo Pugliese
    Meletios A. Dimopoulos
    Lorenzo Ghiadoni
    Greta Barbieri
    Francesco Forfori
    Laura Carrozzi
    Massimo Santini
    Fabio Monzani
    Salvatore De Marco
    Francesco Menichetti
    Agostino Virdis
    Stefano Masi
    Scientific Reports, 11
  • [37] Oral Drugs Against COVID-19
    Mikus, Gerd
    Foerster, Kathrin I.
    Terstegen, Theresa
    Vogt, Cathrin
    Said, Andre
    Schulz, Martin
    Haefeli, Walter E.
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2022, 119 (15): : 263 - +
  • [38] The Prevalence, Risk Factors and Outcome of Cardiac Dysfunction in Hospitalized Patients With Covid-19
    Xie, Mingxing
    Li, Yuman
    Li, He
    Xie, Yuji
    Li, Meng
    Zhang, Li
    CIRCULATION, 2020, 142
  • [39] Antihypertensive drugs and risk of COVID-19?
    Tignanelli, Christopher J.
    Ingraham, Nicholas E.
    Sparks, Matthew A.
    Reilkoff, Ronald
    Bezdicek, Tamara
    Benson, Bradley
    Schacker, Timothy
    Chipman, Jeffrey G.
    Puskarich, Michael A.
    LANCET RESPIRATORY MEDICINE, 2020, 8 (05): : E30 - E31
  • [40] Rapid repurposing of drugs for COVID-19
    Guy, R. Kiplin
    DiPaola, Robert S.
    Romanelli, Frank
    Dutch, Rebecca E.
    SCIENCE, 2020, 368 (6493) : 829 - +
12345